Allied Market Research published a report, titled, "Conjunctivitis Market by Type (Diagnosis and Treatment), by Disease Type ...
Learn the key symptoms of conjunctivitis, how viral, bacterial, and allergic pink eye differ, and when eye redness or discharge needs medical attention.
The approval makes Dupixent the first FDA-approved therapy for allergic fungal rhinosinusitis, supported by Phase III data showing significant improvements in sinus opacification, nasal symptoms, and ...
THE HSE has issued an alert to parents about a condition that needs urgent treatment for kids – and there are five signs to watch out for. Conjunctivitis is an eye condition that requires treatment to ...
As U.S. hospitals face an increasing risk of encountering measles, and pressure to immediately spot it, health care workers ...
Healthcare Asia Magazine on MSN

Global conjunctivitis market to hit $7.2b by 2033

It is driven by rising cases of bacterial, viral, and allergic conjunctivitis The global conjunctivitis market, valued at $4.8b in 2023, is expected to reach $7.2b by 2033, according to Allied Market ...
Dupixent (dupilumab) is now FDA-approved for adults and children aged 6 years and older with allergic fungal rhinosinusitis and prior sino-nasal surgery.
“I could hardly see,” she recalled. “I was losing my vision and nobody was able to tell me why,” she told ABC. The source of ...
Pink eye (conjunctivitis) is inflammation or infection in the conjunctiva, the clear tissue that lines the inside of your eyelid and covers the white part of your eye. It’s one of the most common eye ...
Did you know that someone with measles may not know they have it and can expose you? That's why the spread can be so rapid.
LIBERTY-AFRS-AIMS met its primary endpoint with a 50% reduction in CT sinus opacification at week 52 versus 10% with placebo (P<.0001).
Lee Health this week has had one case of measles, a sign a measles outbreak that started in neighboring Collier County is expanding. “We received the positive result this week,” Lee Health spokeswoman ...